HM van Santen, W Chemaitilly… - Pediatric …, 2020 - pediatric.theclinics.com
Endocrine late effects have been reported in up to 50% of childhood cancer survivors (CCS)> 5 years after treatment. 1–4 Most endocrine disorders are amenable to treatment; …
LC de Kloet, JE Bense, M van der Stoep… - Bone marrow …, 2022 - nature.com
The number of children undergoing hematopoietic stem cell transplantation (HSCT) for nonmalignant diseases has increased in recent years. Endocrine complications are …
A Cattoni, S Molinari, A Gaiero, P De Lorenzo… - … and Cellular Therapy, 2022 - Elsevier
Thyroid late effects are among the most frequent sequelae reported after pediatric hematopoietic stem cell transplantation (HSCT). Although the detrimental effects of …
A Cattoni, S Molinari, B Riva, S Di Marco… - Frontiers in …, 2022 - frontiersin.org
Thyroid disorders (TD) represent a remarkable share of all the late morbidities experienced following pediatric haematopoietic stem cell transplantation (HSCT), with long-term reported …
O Schleicher, A Horndasch, M Krumbholz… - Frontiers in …, 2022 - frontiersin.org
Background Pediatric CML is very rare. Before the introduction of tyrosine kinase inhibitors (TKIs), allogeneic hematopoietic stem cell transplantation (HSCT) from a donor-if available …
We have previously demonstrated a 11% incidence of post‐transplant de novo thyroid disease, even with a radiation‐free RIC regimen. Following the enactment of a universal late …
G Sapuppo, M Tavarelli, E Cannata, M La Spina… - Children, 2021 - mdpi.com
Background: Patients treated for paediatric/adolescent (P/A) neoplasia have a high incidence of both benign and malignant thyroid diseases. Given the high incidence of …
C Sriwichakorn, P Nakavachara… - Pediatric Hematology …, 2023 - Taylor & Francis
The studies of hypothyroidism in children with transfusion-dependent hemoglobin E/β- thalassemia (TDT), especially in those who underwent hematopoietic stem cell …